Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population

References

• Barlas IO, Sezgin M, Erdal ME, Sahin G, Ankarali HC, Altintas ZM, Türkmen E. (2009). Association of (-1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms). Rheumatol Int 29:383–388.
   Google Scholar
• Bayramoglu A, Gunes HV, Metintas M, Degirmenci I, Mutlu F, Alatas F. (2009). The association of MMP-9 enzyme activity, MMP-9 C1562T polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 gene expression in lung cancer. Genet Test Mol Biomarkers 13:671–678.
   PubMed Web of Science ®Google Scholar
• Bian J, Sun Y. (1997). Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol Cell Biol 17:6330–6338.
   PubMed Web of Science ®Google Scholar
• Canniff JP, Harvey W. (1981). The aetiology of oral submucous fibrosis: the stimulation of collagen synthesis by extracts of areca nut. Int J Oral Surg 10:163–167.
   PubMedGoogle Scholar
• Chang YC, Yang SF, Tai KW, Chou MY, Hsieh YS. (2002). Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase: A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. Oral Oncol 38:195–200.
   Google Scholar
• Chaudhary AK, Pandya S, Mehrotra R, Bharti AC, Jain S, Singh M. (2010). Functional polymorphism of the MMP-1 promoter (-1607 1G/2G) in potentially malignant and malignant head and neck lesions in an Indian population. Biomarkers 15:684–692.
   PubMed Web of Science ®Google Scholar
• Chaudhary AK, Pandya S, Mehrotra R, Bharti AC, Singh M, Singh M. (2010). Comparative study between the Hybrid Capture II test and PCR based assay for the detection of human papillomavirus DNA in oral submucous fibrosis and oral squamous cell carcinoma. Virol J 7:253.
   Google Scholar
• Chaudhary AK, Singh M, Bharti AC, Asotra K, Sundaram S, Mehrotra R. (2010). Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck. J Biomed Sci 17:10.
   PubMed Web of Science ®Google Scholar
• Chaudhary AK, Singh M, Bharti AC, Singh M, Shukla S, Singh AK, Mehrotra R. (2010). Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions. BMC Cancer 10:369.
   Google Scholar
• Chaudhary AK, Singh M, Sundaram S, Mehrotra R. (2009). Role of human papillomavirus and its detection in potentially malignant and malignant head and neck lesions: updated review. Head Neck Oncol 1:22.
   PubMedGoogle Scholar
• Deryugina EI, Quigley JP. (2006). Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25:9–34.
   PubMed Web of Science ®Google Scholar
• Egeblad M, Werb Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–174.
   PubMed Web of Science ®Google Scholar
• Elander N, Söderkvist P, Fransén K. (2006). Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Res 26:791–795.
   PubMed Web of Science ®Google Scholar
• Franchi A, Santucci M, Masini E, Sardi I, Paglierani M, Gallo O. (2002). Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer 95:1902–1910.
   PubMed Web of Science ®Google Scholar
• Grieu F, Li WQ, Iacopetta B. (2004). Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype. Breast Cancer Res Treat 88:197–204.
   PubMed Web of Science ®Google Scholar
• Ito I, Nagai S, Handa T, Muro S, Hirai T, Tsukino M, Mishima M. (2005). Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am J Respir Crit Care Med 172:1378–1382.
   PubMed Web of Science ®Google Scholar
• Kawamata H, Nakashiro K, Uchida D, Harada K, Yoshida H, Sato M. (1997). Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines. Int J Cancer 70:120–127.
   PubMed Web of Science ®Google Scholar
• Kawamata H, Uchida D, Hamano H, Kimura-Yanagawa T, Nakashiro KI, Hino S, Omotehara F, Yoshida H, Sato M. (1998). Active-MMP2 in cancer cell nests of oral cancer patients: correlation with lymph node metastasis. Int J Oncol 13:699–704.
   Google Scholar
• Ko SY, Lin SC, Chang KW, Liu CJ, Chang SS, Lu SY, Liu TY. (2003). Modulation of KGF-1 gene expression in oral fibroblasts by ripe areca nut extract. J Oral Pathol Med 32:399–407.
   Google Scholar
• Kurahara S, Shinohara M, Ikebe T, Nakamura S, Beppu M, Hiraki A, Takeuchi H, Shirasuna K. (1999). Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 21:627–638.
   PubMed Web of Science ®Google Scholar
• Kusukawa J, Sasaguri Y, Shima I, Kameyama T, Morimatsu M. (1993). Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study. Am J Clin Pathol 99:18–23.
   PubMed Web of Science ®Google Scholar
• Lei H, Hemminki K, Altieri A, Johansson R, Enquist K, Hallmans G, Lenner P, Försti A. (2007). Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression. Breast Cancer Res Treat 103:61–69.
   PubMed Web of Science ®Google Scholar
• Lichtinghagen R, Bahr MJ, Wehmeier M, Michels D, Haberkorn CI, Arndt B, Flemming P, Manns MP, Boeker KH. (2003). Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis. Clin Sci 105:373–382.
   PubMed Web of Science ®Google Scholar
• Lin SC, Chen YJ, Kao SY, Hsu MT, Lin CH, Yang SC, Liu TY, Chang KW. (2002). Chromosomal changes in betel-associated oral squamous cell carcinomas and their relationship to clinical parameters. Oral Oncol 38:266–273.
   Google Scholar
• Lin SC, Chung MY, Huang JW, Shieh TM, Liu CJ, Chang KW. (2004). Correlation between functional genotypes in the matrix metalloproteinases-1 promoter and risk of oral squamous cell carcinomas. J Oral Pathol Med 33:323–326.
   Google Scholar
• Lin SC, Liu CJ, Yeh WI, Lui MT, Chang KW, Chang CS. (2006). Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett 243:47–54.
   PubMed Web of Science ®Google Scholar
• Lin SC, Lo SS, Liu CJ, Chung MY, Huang JW, Chang KW. (2004). Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. J Oral Pathol Med 33:405–409.
   Web of Science ®Google Scholar
• Matsumura S, Oue N, Nakayama H, Kitadai Y, Yoshida K, Yamaguchi Y, Imai K, Nakachi K, Matsusaki K, Chayama K, Yasui W. (2005). A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol 131:19–25.
   Google Scholar
• Medley TL, Cole TJ, Dart AM, Gatzka CD, Kingwell BA. (2004). Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol 24:1479–1484.
   PubMed Web of Science ®Google Scholar
• Mehrotra R, Chaudhary AK, Pandya S, Debnath S, Singh M, Singh M. (2010). Correlation of addictive factors, human papilloma virus infection and histopathology of oral submucous fibrosis. J Oral Pathol Med 39:460–464.
   Google Scholar
• Mehrotra R, Pandya S, Chaudhary AK, Kumar M, Singh M. (2008). Prevalence of oral pre-malignant and malignant lesions at a tertiary level hospital in Allahabad, India. Asian Pac J Cancer Prev 9:263–265.
   PubMed Web of Science ®Google Scholar
• Miao X, Yu C, Tan W, Xiong P, Liang G, Lu W, Lin D. (2003). A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res 63:3987–3990.
   Google Scholar
• Mignatti P, Rifkin DB. (1993). Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73:161–195.
   PubMed Web of Science ®Google Scholar
• Morgan AR, Zhang B, Tapper W, Collins A, Ye S. (2003). Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. J Mol Med 81:321–326.
   PubMed Web of Science ®Google Scholar
• Nagase H, Woessner JF Jr. (1999). Matrix metalloproteinases. J Biol Chem 274:21491–21494.
   PubMed Web of Science ®Google Scholar
• Okamoto K, Mimura K, Murawaki Y, Yuasa I. (2005). Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. J Gastroenterol Hepatol 20:1102–1108.
   PubMed Web of Science ®Google Scholar
• Pandya S, Chaudhary AK, Singh M, Singh M, Mehrotra R. (2009). Correlation of histopathological diagnosis with habits and clinical findings in oral submucous fibrosis. Head Neck Oncol 1:10.
   Google Scholar
• Patel SG, Shah JP. (2005). TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 55:242–58; quiz 261.
   Google Scholar
• Pindborg JJ, Sirsat SM. (1966). Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 22:764–779.
   PubMedGoogle Scholar
• Price SJ, Greaves DR, Watkins H. (2001). Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 276:7549–7558.
   PubMed Web of Science ®Google Scholar
• Qin H, Sun Y, Benveniste EN. (1999). The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 274:29130–29137.
   PubMed Web of Science ®Google Scholar
• Rajalalitha P, Vali S. (2005). Molecular pathogenesis of oral submucous fibrosis–a collagen metabolic disorder. J Oral Pathol Med 34:321–328.
   Google Scholar
• Roehe AV, Frazzon AP, Agnes G, Damin AP, Hartman AA, Graudenz MS. (2007). Detection of polymorphisms in the promoters of matrix metalloproteinases 2 and 9 genes in breast cancer in South Brazil: preliminary results. Breast Cancer Res Treat 102:123–124.
   Google Scholar
• Shieh TY, Yang JF. (1992). Collagenase activity in oral submucous fibrosis. Proc Natl Sci Counc Repub China B 16:106–110.
   Google Scholar
• Tu HF, Wu CH, Kao SY, Liu CJ, Liu TY, Lui MT. (2007). Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users. J Oral Pathol Med 36:409–414.
   PubMed Web of Science ®Google Scholar
• Vairaktaris E, Vassiliou S, Nkenke E, Serefoglou Z, Derka S, Tsigris C, Vylliotis A, Yapijakis C, Neukam FW, Patsouris E. (2008). A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol 34:450–455.
   PubMed Web of Science ®Google Scholar
• Visse R, Nagase H. (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827–839.
   PubMed Web of Science ®Google Scholar
• Wagenaar-Miller RA, Gorden L, Matrisian LM. (2004). Matrix metalloproteinases in colorectal cancer: is it worth talking about? Cancer Metastasis Rev 23:119–135.
   PubMed Web of Science ®Google Scholar
• Westermarck J, Kähäri VM. (1999). Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13:781–792.
   PubMed Web of Science ®Google Scholar
• Woo M, Park K, Nam J, Kim JC. (2007). Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol 22:1064–1070.
   Google Scholar
• Xing LL, Wang ZN, Jiang L, Zhang Y, Xu YY, Li J, Luo Y, Zhang X. (2007). Matrix metalloproteinase-9-1562C>T polymorphism may increase the risk of lymphatic metastasis of colorectal cancer. World J Gastroenterol 13:4626–4629.
   PubMed Web of Science ®Google Scholar
• Xu E, Xia X, Lü B, Xing X, Huang Q, Ma Y, Wang W, Lai M. (2007). Association of matrix metalloproteinase-2 and -9 promoter polymorphisms with colorectal cancer in Chinese. Mol Carcinog 46:924–929.
   Google Scholar
• Xu EP, Huang Q, Lu BJ, Xing XM, Lai MD. (2006). The correlation between polymorphisms of matrix metalloproteinase-2 and -9 genes and colorectal cancer of Chinese patients. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23:78–81.
   Google Scholar
• Ye S. (2000). Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 19:623–629.
   PubMed Web of Science ®Google Scholar
• Yorioka CW, Coletta RD, Alves F, Nishimoto IN, Kowalski LP, Graner E. (2002). Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients. Int J Oncol 20:189–194.
   PubMed Web of Science ®Google Scholar
• Yoshizaki T, Maruyama Y, Sato H, Furukawa M. (2001). Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int J Cancer 95:44–50.
   PubMed Web of Science ®Google Scholar
• Yu C, Pan K, Xing D, Liang G, Tan W, Zhang L, Lin D. (2002). Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res 62:6430–6433.
   PubMed Web of Science ®Google Scholar
• Zhang B, Henney A, Eriksson P, Hamsten A, Watkins H, Ye S. (1999). Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet 105:418–423.
   PubMed Web of Science ®Google Scholar
• ZhouY, Yu C, Miao X, Wang Y, Tan W, Sun T, Zhang X, Xiong P, Lin D. (2005). Functional haplotypes in the promoter of matrix metalloproteinase- 2 and lung cancer susceptibility. Carcinogenesis 26:1117–1121.
   PubMed Web of Science ®Google Scholar